Objectives: To investigate whether gender is associated with three recommended stages of the HIV care continuum and whether gender modifies known associations between level of alcohol use and HIV care among US veterans.
Introduction
Despite medical advances that help improve health and slow transmission, HIV is common in the US [1] . To effectively treat and prevent HIV, the Joint United Nations Programme on HIV and AIDS [2] recommends monitoring care targets considered essential, collectively referred to as the HIV care continuum [3] . These include: diagnosis, linkage to HIV care, engagement in care, treatment with antiretroviral therapy (ART), and achievement of viral suppression [2, 4] .
In the United States, HIV primarily affects men [1] . However, incidence in women rose in the last two decades [5] , and, though now declining [1] , women make up 25% of people with HIV (PWH) [1] . For heterosexual acquisition, women are physiologically more susceptible to HIV than men [5, 6] and have increased exposure to social determinants of health that may increase treatment barriers and disease susceptibility [7, 8] .
Women may also be more vulnerable than men to the impact of modifiable behavioral factors such as alcohol use that adversely affect HIV-related care and outcomes [9] . Whether gender modifies known associations between level of alcohol use and HIV care among US veterans is unknown. Understanding gender-specific effects of alcohol use on receipt of HIV treatment and outcomes may help develop targeted interventions to increase engagement in HIV care and, ultimately, improve HIV-related outcomes for women and men.
As the nation's largest integrated healthcare system and largest provider of HIV care, the Veterans Health Administration (VA) is an ideal laboratory in which to address these issues [4, 10, 11] . In a national cohort of PWH receiving VA care, we (1) examine gender differences in HIV care continuum outcomes, and (2) assess whether gender modifies associations between level of alcohol use and HIV care continuum outcomes.
Methods
Data source and study cohort We used national VA electronic health records (EHR) data from the Veterans Aging Cohort Study (VACS) [10, 12] to identify all patients aged 25-84 with documented HIV and alcohol screening between 1 February 2008, when screening results became widely available [13] , and 30 September 2014. International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes determined HIV status based on two outpatient or one inpatient diagnosis code(s) for AIDS (042) and/or HIV infection (V08) [10, 14] .
Measures
Gender Gender was measured dichotomously as man or woman based on EHR documentation at the time of VACS enrollment.
Level of alcohol use

Level of alcohol use was measured with the Alcohol Use Disorders Identification Test Consumption (AUDIT-C).
The AUDIT-C is administered annually to more than 90% of established VA outpatients, with results documented in the EHR [15] . AUDIT-C scores range from 0 to 12 points; higher scores reflect greater consumption, probability of alcohol use disorder [16] , and risk of mortality [17] . The first documented AUDIT-C after VACS enrollment was categorized into five levels of alcohol use: nondrinking (AUDIT-C 0), low (1-3 men/ 1-2 women), medium (4-5 men/3-5 women), high (6-7), and very high (8) (9) (10) (11) (12) .
Outcomes
Three HIV care continuum outcomes were measured in the year following AUDIT-C: engagement in HIV care based on any documentation of CD4 þ (cells/ml) or HIV viral load (copies/ml) lab values [18] ; on ART, defined as having filled at least one prescription for any antiretroviral medication [18] ; and viral suppression measured as having HIV RNA less than 500 copies/ml [19] on the first available measure following AUDIT-C (<500 copies/ml has remained a target threshold over time even as assays have gotten more sensitive) [20] .
Covariates
Covariates included age at the time of alcohol screening (<50, 50-65, >65); race/ethnicity (black, Hispanic, white, and other/unknown) based on EHR documentation; year of AUDIT-C screening; and dichotomous measures of any mental health disorder (depressive disorder, anxiety, or serious mental illness including schizophrenia, bipolar, and schizoaffective disorders), alcohol use disorder (abuse, dependence, or alcoholrelated conditions including cirrhosis), and drug use disorder (opioid, stimulant, cannabis, or other) based on ICD-9-CM codes in the year prior to AUDIT-C.
Analyses
First, we compared cohort characteristics and level of alcohol use by gender using chi-square tests. Next, we used modified Poisson regression models with robust error variances to estimate relative rates of HIV care continuum outcomes for women compared with men. Poisson was used because outcomes were expected to be common [21, 22] . As we hypothesized a priori that gender would modify associations between level of alcohol use and HIV care outcomes, we also fit models that additionally included level of alcohol use and a multiplicative interaction between gender and alcohol use to estimate gender-specific effects of alcohol use. Nondrinking (AUDIT-C ¼ 0) was the referent category because research suggests this level is associated with the lowest level of risk for PWH [9] . We tested whether the relationship between level of alcohol use and each outcome was linear using orthogonal polynomial contrast tests. All models were first unadjusted and then adjusted for all covariates. Unadjusted models were considered primary because they reflect existing differences; adjusted models were fit to account for measured factors that may drive gender and alcohol-related differences in HIV care. To understand the clinical implications of differences in outcomes, we estimated predicted prevalences based on the unadjusted models using recycled predictions.
As past-year nondrinking does not differentiate between lifetime abstainers and 'sick-quitters,' [23] we conducted sensitivity analyses excluding PWH reporting no alcohol use (AUDIT-C ¼ 0), with low-level drinking as the referent.
Analyses were conducted using Stata 14 software [24] . Study procedures were approved by VA Connecticut Healthcare System IRB.
Results
Study cohort characteristics
Among 39 239 VA PWH alive at the start of the study period, 33 224 (85%) had AUDIT-C screening and were included in analyses. Of these, 971 were women and 32 253 were men. Sixty-four percentage were 50 years and older, 48% were black race/ethnicity, and 36% reported any mental health disorder. Nearly half (47%) reported nondrinking and 39%, 8%, 3%, and 4% reported low-level, medium-level, high-level, and very high-level drinking, respectively. On average, women were younger than men, more likely to be black race/ethnicity, have mental health disorders, and less likely to report mediumlevel, high-level, and very high-level drinking (Supplemental File 1, http://links.lww.com/QAD/B327).
Gender and HIV care continuum Women were less likely than men to be engaged in HIV medical care, on ART, and virally suppressed (Table 1 ). Figure 1 shows the predicted prevalence of PWH receiving each element of the HIV care continuum by gender. Results were similar after adjustment.
Alcohol use and HIV care continuum by gender There was no statistically significant interaction between level of alcohol use and HIV care continuum outcomes (in primary analyses, interaction term P values were 0.30, 0.43 and 0.60 for engagement in HIV care, receipt of ART, and viral suppression, respectively). However, gender-stratified models suggested possible variability. Among women, very high-level drinking was associated with decreased likelihood of ART and viral suppression (but not engagement in HIV medical care) relative to nondrinking. Other levels of alcohol use were not associated with outcomes, although numbers of women in these groups were small and confidence intervals wide (Table 1) . Among men, relative to nondrinking, low-level drinking was associated with slightly increased likelihood of engaging in HIV medical care and ART whereas all other levels of alcohol use were associated with decreased likelihood of care continuum outcomes ( Table 1) .
Level of alcohol use was significantly inversely associated with all care continuum outcomes for both genders except engagement in HIV care among women. At every level of alcohol use, women had lower rates of HIV care continuum outcomes than men (Fig. 1) . All results were similar after adjustment.
Results of sensitivity analyses were comparable with primary results, although confidence intervals among women were much larger, likely because of reduced sample size (not shown).
Discussion
In this large national cohort of PWH, gender disparities in key markers of effective HIV care were observed. Women were less likely than men to meet each HIV care continuum target, with fewer than half virally suppressed. At every level of alcohol use, women appeared to have poorer HIV care continuum outcomes than men. Further, the magnitude of reduction in rates of target care associated with very high-level drinking compared with nondrinking was much greater in women compared with men. Gender-specific findings regarding level of alcohol use and HIV care continuum outcomes are concerning. Women with HIV may experience social vulnerabilities that increase alcohol-related risk and interfere with receipt of HIV care. In this cohort of women, almost two-thirds were black and half had clinically identified mental health disorders. Both black race and mental health disorders are associated with stigma and discrimination that adversely influence HIV outcomes [1, [25] [26] [27] . Very high-level drinking adds synergistic risk [28, 29] . Women may also experience metabolic vulnerabilities whereby they suffer negative consequences of alcohol consumption faster and to a greater degree than men [30] . Such consequences have been documented for cognition, motor functioning, and reproductive health [30] . This is the first study to our knowledge to suggest that women with HIV and higher level alcohol use may experience more severe HIV-related outcomes than men with the same conditions. Targeted interventions [31] may be needed to improve care and outcomes for women with HIV, particularly those with multiple and intersecting identities and comorbid conditions that increase risk.
Gender, alcohol use, and the HIV care continuum Matson et al. 2251 This study has several limitations. First, power to detect associations between alcohol use and HIV care continuum outcomes among women may have been limited by smaller numbers of women with higher levels of alcohol use. Second, the EHR does not capture sexual orientation and may misclassify gender identity for some patients. Third, alcohol use may have been underreported by patients [13, 32] and underestimated by clinically documented screening [33] . Fourth, the reference category (AUDIT-C ¼ 0) includes both PWH with lifetime abstinence and those who became abstinent because of declining health. The latter may be medically complex patients for whom additional barriers to HIV care exist [34] . However, sensitivity analyses with lowlevel drinking as the referent suggested similar patterns. Finally, although we studied a national cohort, findings may not be generalizable to non-VA populations. Although racially and ethnically diverse, VA PWH may be older on average than PWH in the general population. Additionally, care that women with HIV receive at VA may differ from non-VA care (e.g. care by Ryan White services). Women receiving non-VA care may experience even greater disparities, given that VA is an integrated system with free HIV care. Alternatively, as a minority group in a health system traditionally serving men, women may face more barriers within VA.
This large nationally representative study builds on previous research by examining gender disparities across HIV care continuum outcomes [35] and provides further evidence [9] Views presented in the manuscript are those of the authors and do not reflect those of the University of Washington, the Department of Veterans Affairs, or the United States Government.
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